Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "biosciences"

116 News Found

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News | June 07, 2022

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price


Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape
Biotech | May 23, 2022

Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape

The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer


Neurocrine Biosciences receives Orphan Drug Designation for Valbenazine
Biotech | May 13, 2022

Neurocrine Biosciences receives Orphan Drug Designation for Valbenazine

The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation


Akston Biosciences doses first participants in Phase II clinical trial for Covid-19 booster
Biotech | May 13, 2022

Akston Biosciences doses first participants in Phase II clinical trial for Covid-19 booster

AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022


Terran Biosciences announces licensing deal with Sanofi
Biotech | April 22, 2022

Terran Biosciences announces licensing deal with Sanofi

Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics


Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Biotech | April 13, 2022

Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells

Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


Oragnon enters global licencing agreement with Dare Biosciences
News | April 01, 2022

Oragnon enters global licencing agreement with Dare Biosciences

An estimated 21 million American women experience BV


Sanofi and IGM Biosciences team up to commercialise IgM antibody agonists
Biotech | March 30, 2022

Sanofi and IGM Biosciences team up to commercialise IgM antibody agonists

Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets


Hester Biosciences foray into pet care industry
News | March 22, 2022

Hester Biosciences foray into pet care industry

Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products